Victrix Computational Chemistry and Medicinal Chemistry Consultancy
Contact us
  • Home
  • Philosophy
  • Services
  • Our Clients
  • Contact
  • About
    • Press Releases
  • Victrix Sounds Off
  • Blog

I'm Back

5/6/2018

0 Comments

 
Picture
In April 2014 I took a permanent position.  I still had a few clients and I worked with them through the end of the year.  The end of the year also brought the end of my 23-year-old marriage.  Many more changes some I shouldn’t talk about some I wont talk about and some I will.
 
What’s different:
  1. I’ve met the love of my life, a similarly recently divorced woman with Multiple Sclerosis.
  2. We have lost three of our long-time companions, Biggles, Scout and Peanut, and gained a new one, Crash the Wonder Dog
  3. My best friend, who I have know since age 12 and was the brother nature deprived me of, passed untimely of a very rare cancer, large cell neuroendocrine cancer of the colon.
  4. My cluster headaches have returned after a 15-year remission and lead to a battle to stabilize it.
What’s the same:
  1. I still believe small molecules are the most efficient method to treat disease
  2. I still think CDD Vault is the best collaborative data management system available in the pharmaceutical industry
  3. I still believe strongly in 3D QSAR and think CRESSET has the market locked up.
So what am I doing back.  I will be blogging more regularly now.  I also was to say if you are a 501-C3 looking for some computational support, or a small startup with people working for minimum wage, subsisting or trying to get SBIR grants, I am the kind of consultant you are looking for.  As long as there is not a conflict of interest with what I am doing for my employer, I am interested in pro bono or innovative remuneration schemes.  You probably can’t afford to hire me.  So, do let that worry you.  I have my own personal suite of software and I can bring it to bear on your problems, at the low, low cost of free, if you can interest me in the project.  I am particularly interested in demyelinating diseases, drug resistant infectious diseases and neglected tropical diseases.  Send me and email!

0 Comments

    Adam Kallel Ph. D.

    Our CSO sounds off about drug discovery, computational chemistry and history

    Archives

    May 2018
    March 2014
    January 2014
    October 2013
    September 2013
    August 2013
    July 2013
    June 2013
    May 2013
    April 2013
    March 2013

    Categories

    All
    Ageing
    Amphetamine
    Anti-virals
    Biography
    Broken Society
    Caffeine
    Cancer
    Cd26
    Cluster Headache
    Colic
    Collaboration
    Corona Virus
    Danger Danger
    Depression
    Drug Discovery
    Drug Resistence
    Economy Of Scale
    Electron Microscopy
    Emergent Infectious Disease
    Encephalitis Lethargica
    Global Epidemiology
    Goal Setting
    HCoV-EMC
    Hiring
    Incorrect Pathologizing
    Incretin
    Influenza
    Jobs
    Me
    Merck
    Mergers
    Metabolic Disease
    Migraine
    Nerd
    Neurotransmiters
    Open Positions
    Over Prescription
    Overwork
    Pharma
    Pharmaceutical Industry
    Restructuring
    Stimulants
    Telomerase
    Tuberculosis
    Viral Replication
    Virus

    RSS Feed

    comments powered by Disqus
    View my profile on LinkedIn
Powered by Create your own unique website with customizable templates.